<i>RET</i>-Altered Cancers-A Tumor-Agnostic Review of Biology, Diagnosis and Targeted Therapy Activity.

Desilets, Antoine; Repetto, Matteo; Yang, Soo-Ryum; Sherman, Eric J; Drilon, Alexander

RET-Altered Cancers-A Tumor-Agnostic Review of Biology, Diagnosis and Targeted Therapy Activity.

Desilets, Antoine; Repetto, Matteo; Yang, Soo-Ryum; Sherman, Eric J; Drilon, Alexander.

Afiliación

Desilets A; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Repetto M; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Yang SR; Department of Oncology and Hemato-Oncology, University of Milan, 20133 Milan, Italy.
Sherman EJ; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Drilon A; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Cancers (Basel) ; 15(16)2023 Aug 17.

Article en En | MEDLINE | ID: mdl-37627175

Palabras clave

RET fusion; RET mutation; pralsetinib; selpercatinib; tumor agnostic

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google